$0.9080
0.011.34%
At close: -
$0.8803
-0.03-3.05%
After Hours: 7:46 PM EDT
Comments
Loading...
Jupiter Neurosciences (JUNS) Forecast
NewsEarningsJupiter Neurosciences (JUNS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestJupiter Neurosciences (NASDAQ:JUNS) Stock Quotes, Forecast and News Summary
Jupiter Neurosciences Stock (NASDAQ: JUNS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Jupiter Neurosciences (JUNS) stock?
You can purchase shares of Jupiter Neurosciences (NASDAQ:JUNS) through any online brokerage.
Who are Jupiter Neurosciences (JUNS) competitors?
Other companies in Jupiter Neurosciences’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX) and CalciMedica (NASDAQ:CALC).
What is the forecast, or price target, for Jupiter Neurosciences (JUNS) stock?
There is no analysis for Jupiter Neurosciences to provide a consensus price target.
What is the current price for Jupiter Neurosciences (JUNS)?
The stock price for Jupiter Neurosciences (NASDAQ: JUNS) is $0.8803 last updated February 11, 2025 at 7:46 PM EST.
Does Jupiter Neurosciences (JUNS) pay a dividend?
There are no upcoming dividends for Jupiter Neurosciences.
When is Jupiter Neurosciences (NASDAQ:JUNS) reporting earnings?
Jupiter Neurosciences’s Q1 earnings are confirmed for Sunday, May 11, 2025.
Is Jupiter Neurosciences (JUNS) going to split?
There is no upcoming split for Jupiter Neurosciences.
What sector and industry does Jupiter Neurosciences (JUNS) operate in?
Jupiter Neurosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.